7 Drugs Approved for Primary Care: Q4 2024

News
Slideshow

An oral antibiotic for drug-resistant UTIs, a long-awaited therapy for congenital adrenal hyperplasia, and more.

The fourth quarter has come and gone, which means Patient Care Online has compiled another list of drugs approved by the US FDA for conditions that are often seen in primary care. In the slides above, find details on a new treatment for obstructive sleep apnea in patients with obesity, an oral antibiotic for drug-resistant urinary tract infections, a long-awaited therapy for congenital adrenal hyperplasia, and 4 more.


For more information on key FDA approvals from 2024, check out:

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2025 MJH Life Sciences

All rights reserved.